Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
105.10
(
0.00%
)
Bitcoin
68,371.99
(
-0.75%
)
News Focus
News Focus
Post# of 257269
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 24757

Thursday, 02/15/2007 12:55:45 PM

Thursday, February 15, 2007 12:55:45 PM

Post# of 257269
Tysabri vs Copaxone Revisited

A year ago, this board ran a survey on which of these drugs will have larger sales in 2007-2009. Tysabri outpolled Copaxone by almost 2:1:

http://www.investorshub.com/boards/board_survey_results.asp?board_id=1418&Survey_Num=47

It looks like the majority of survey voters got it wrong. 4Q06 worldwide sales of Tysabri (reported today by BIIB) were $30M. 4Q06 worldwide sales of Copaxone were $378M.

I think it’s not unreasonable to think that Copaxone will continue to outsell Tysabri by about 10:1.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today